Latest ebit for STRM: $-2.8B, below the Technology sector average of $14T.
Get informed when a big investor buys or sells
+ FollowAs of Apr 30, 2025
Trailing 12 months ending Apr 30, 2025
Streamline Health Solutions (STRM) currently reports a EBIT of $-2.8B as of April 2025. That compares with $-7.3M in the prior-year period — down 38083.0% year over year. That is below the Technology sector average of $14T. Use the charts on this page to explore Streamline Health Solutions's EBIT history and peer comparisons.
Streamline Health Solutions's EBIT decreased from $-7.3M to $-2.8B — a 38083.0% year-over-year decrease (period ending April 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Streamline Health Solutions's EBIT of $-2.8B is lower than the Technology sector average of $14T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Streamline Health Solutions reported $-2.8B in EBIT as of April 2025. That compares with $-7.3M in the prior-year period — down 38083.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $-2.8B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is $14T. From there, open related valuation or income-statement pages for Streamline Health Solutions, and consider following STRM for alerts when major investors trade the stock.